Home 2015
Archives
FDA Approves Novel Leg Prosthesis for AKAs
New device adheres to the leg with fixtures and screws implanted into the remaining thigh bone
FDA Approves Rexulti for Schizophrenia, Depression
But shouldn't be prescribed to some older people
FDA Approves Iressa for EGFR+ Metastatic Lung Cancer
New companion diagnostic kit can identify candidates
FDA Strengthens Heart Attack, Stroke Warning for NSAIDs
Aspirin not included in alert
Poll Finds More Parents See Benefits, Safety of Vaccines
Reports on outbreaks of measles, pertussis in past year may have shifted opinions, pediatrician says
ACIP Recommends MenB Vaccine for 16- to 23-Year-Olds
Category B recommendation for short-term protection against meningitis for all aged 16 to 23
WHO’s Response to Ebola Slowed by Politics, Bureaucracy
Independent, international panel says affected countries acted slowly, WHO is underfunded
FDA Approves Entresto for Heart Failure
Medication helps reduce the rate of cardiovascular death, hospitalization
Asbestos Found in Children’s Crayons, Toy Crime Lab Kits
Health experts, big retailer say they're concerned about findings on products from China
CDC: BBQ Grill Brush Wires Can Cause Serious GI Injury
If ingested, stray wire bristles can pierce throat, intestines, public health experts warn


![FDA Approves Iressa for EGFR+ Metastatic Lung Cancer Iressa (gefitinib) has been approved by the U.S. Food and Drug Administration to treat patients with metastatic non-small-cell lung cancer with a specific genetic mutation (epidermal growth factor receptor [EGFR]). A just-approved companion diagnostic test can identify patients who could benefit from this new use.](https://www.ehealth-news.com/wp-content/uploads/2016/01/fdalogo-6-180x84.jpg)









